Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AWH
Aspira Women's Health Inc. Common Stock
stock NASDAQ

Inactive
Apr 16, 2025
0.0820USD-12.487%(-0.0117)4,742,494
Pre-market
0.00USD-100.000%(-0.09)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 31, 2022
04:05PM EST  Aspira Womens Health Announces the Addition of   GlobeNewswire Inc
Jan 5, 2022
08:00AM EST  Aspira Womens Health Executes an Agreement with   GlobeNewswire Inc
08:00AM EST  Aspira Womens Health Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that Minh Merchant will join the Company as General Counsel and Corporate Secretary, effective Jan. 4, 2022. In this role, Ms. Merchant will lead the Companys legal, compliance, and enterprise risk management functions, reporting to Valerie Palmieri, CEO.   GlobeNewswire Inc
08:00AM EST  Aspira Womens Health Announces Fourth Quarter   GlobeNewswire Inc
Nov 10, 2021
08:22AM EST  Aspira Womens Health Q3 EPS $(0.09) Misses $(0.07) Estimate, Sales $1.67M Beat $1.62M Estimate   Benzinga
08:00AM EST  Total Revenue Increased 34% to $1.67 million; OVA1 Volume Grew 19% to 4,281 Units   GlobeNewswire Inc
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 1, 2021
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will report financial results for the third quarter ended September 30, 2021 on Wednesday, November 10, 2021, before the market open, followed by an investor conference call and webcast at 8:30 a.m. Eastern Time.   GlobeNewswire Inc
Oct 7, 2021
08:16AM EDT  Genoox And Aspira Women's Health Inc. Partner To Develop And Deliver Data-Driven Insights To Advance Women's Health   Benzinga
08:00AM EDT  Genoox, the worlds largest community-driven genomic data platform, and Aspira Womens Health Inc. (Aspira) (Nasdaq: AWH), a bioanalytical-based womens health company, today announced a partnership to develop solutions to advance women's health with rapid results, diagnosis, and insights.   GlobeNewswire Inc
Sep 30, 2021
08:00AM EDT  Aspira Womens Health, Black   GlobeNewswire Inc
Sep 29, 2021
08:00AM EDT  Aspira Womens Health Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, announced today that it has exceeded its anticipated commercial milestones for Aspira Synergy, the companys technology transfer solution that launched in the second quarter of 2021.   GlobeNewswire Inc
Sep 21, 2021
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will present at the Cantor Fitzgerald Virtual Global Healthcare Conference on Wednesday, September 29th, 2021.   GlobeNewswire Inc
Sep 9, 2021
08:00AM EDT  Aspira Womens Health Kicks Off Ovarian Cancer   GlobeNewswire Inc
Aug 12, 2021
05:27PM EDT  Recap: Aspira Womens Health Q2 Earnings   Benzinga
05:00PM EDT  Aspira Womens Health Q2 EPS $(0.06), Inline, Sales $1.80M Beat $1.61M Estimate   Benzinga
04:05PM EDT  Total Revenue Increased 141% to $1.8 million; OVA1 Volume Grew 85% to 4,553 Accessions   GlobeNewswire Inc
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Jul 27, 2021
04:01PM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will report financial results for the second quarter ended June 30, 2021 on Thursday, August 12, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Jul 8, 2021
08:57AM EDT  -- AIM is a member of the Anthem Blue Cross Blue Shield family of companies which promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. -- AIM is a wholly owned subsidiary of Anthem, Inc., serving more than 50 million members across 50 states, D.C. and US territories.   GlobeNewswire Inc
08:08AM EDT  Aspira Women's Health Highlights Coverage For OVA1 In AIM Specialty Health Laboratory Medicine Clinical Guidelines   Benzinga
08:00AM EDT  Aspira Womens Health Inc.   GlobeNewswire Inc
Jun 3, 2021
08:00AM EDT  Aspira Womens Health Releases Analytical and   GlobeNewswire Inc
May 19, 2021
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that management will participate in and present at the William Blair Growth Stock Conference on June 1-3, 2021. Details for the event are below:   GlobeNewswire Inc
May 13, 2021
08:10AM EDT  Aspira Womens Health Q1 Sales $1.42M Beat $1.37M Estimate   Benzinga
08:01AM EDT  Aspira Womens Health Inc. (Aspira) (Nasdaq: AWH), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the first quarter ended, March 31, 2021.   GlobeNewswire Inc
08:00AM EDT  - Analytical and Initial Clinical Validation performance for Aspiras OVASightblood-based biomarker test for Ovarian Malignancy risk assessment in women with Adnexal Masses.- Data demonstrates the ability to identify Ovarian Cancer Risk in a low prevalence population   GlobeNewswire Inc
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 12, 2021
04:27PM EDT  Aspira Women's Health Initiates Prospective Clinical Study For Benign Risk Monitoring And High Risk Early Ovarian Cancer Detection With Northwell Health   Benzinga
04:05PM EDT  Aspira Womens Health Initiates Prospective   GlobeNewswire Inc
May 11, 2021
04:05PM EDT  Aspira Womens Health, Inc. Expands Leadership   GlobeNewswire Inc
May 5, 2021
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will report financial results for the first quarter ended March 31, 2021 on Thursday, May 13, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Mar 29, 2021
10:04AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2021   Benzinga
07:33AM EDT  Truist Securities Initiates Coverage On Aspira Womens Health with Buy Rating, Announces Price Target of $12   Benzinga
Mar 25, 2021
04:29PM EDT  Aspira Womens Health Q4 EPS $(0.58) Down From $(0.03) YoY, Sales $1.45M Beat $1.30M Estimate   Benzinga
04:21PM EDT  Aspira Womens Health Inc. (Aspira) (Nasdaq: AWH), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended December 31, 2020.   GlobeNewswire Inc
04:02PM EDT  Aspira Women's Health, Inc. Announces An Agreement For The Development And Commercialization Of An Early-Detection Test For Identification Of Ovarian Cancer   Benzinga
04:01PM EDT  Aspira Womens Health, Inc. Announces an   GlobeNewswire Inc
04:03AM EDT  Earnings Scheduled For March 25, 2021   Benzinga
Mar 18, 2021
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will report financial results for the fourth quarter and full year ended December 31st, 2020, on Thursday, March 25th, 2021, after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Mar 15, 2021
08:00AM EDT  Aspira Womens Health Inc. Announcement New York   GlobeNewswire Inc
Feb 22, 2021
08:45AM EST  Aspira Women's Health Adds Nicole Sandford To Its Board   RTTNews
08:30AM EST  Aspira Womens Health Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors.   GlobeNewswire Inc
Feb 17, 2021
08:00AM EST  Aspira Womens Health Recognizes the Importance   GlobeNewswire Inc
Feb 12, 2021
04:18PM EST  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place on February 17-19. Details for the event are below:   GlobeNewswire Inc
Feb 10, 2021
05:38PM EST  Aspira Womens Health, Inc. to add NCCN   GlobeNewswire Inc
Feb 4, 2021
10:18AM EST  Shares of Aspira Women's Health Inc. (AWH) are losing over 15% on Thursday morning. The company said it priced $45 million offering of common stock.   RTTNews
09:25AM EST  Aspira Women's Health Announces $45M Public Offering At $7.50/Share   Benzinga
09:25AM EST  Aspira Womens Health Inc. Announces Pricing of   GlobeNewswire Inc
Feb 3, 2021
04:07PM EST  Aspira Women's Health Announces A Common Stock Offering; No Terms Disclosed   Benzinga
04:04PM EST  Aspira Womens Health Inc. Announces Proposed   GlobeNewswire Inc
Jan 29, 2021
12:13PM EST  Aspira Womens Health Option Alert: Feb 19 $12.5 Calls at the Ask: 1000 @ $0.75 vs 12 OI; Ref=$10.2199   Benzinga
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 29, 2021   Benzinga
06:14AM EST  Cantor Fitzgerald Initiates Coverage On Aspira Womens Health with Overweight Rating, Announces Price Target of $10   Benzinga
Jan 28, 2021
08:00AM EST  Aspira Womens Health Inc. Announces it is Now a   GlobeNewswire Inc
Jan 4, 2021
04:34PM EST  Aspira to participate in the 10th Annual LifeSci Advisors Corporate Access Event andBiotech Showcase from January 6 15th, 2021   GlobeNewswire Inc
Nov 19, 2020
08:04AM EST  Aspira Women's Health, Inc. Announces A Collaborative Agreement With Baylor Genetics For Co-Development Of An Ovarian Cancer Early-Detection Test   Benzinga
08:00AM EST  Aspira Womens Health, Inc. Announces a   GlobeNewswire Inc
Nov 12, 2020
04:03PM EST  Aspira Womens Health Q3 EPS $(0.04), Same YoY, Sales $1.24M Beat $922.00K Estimate   Benzinga
04:01PM EST  Aspira Womens Health Inc. (ASPIRA) (Nasdaq: AWH), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the third quarter ended September 30, 2020.   GlobeNewswire Inc
04:18AM EST  Earnings Scheduled For November 12, 2020   Benzinga
Nov 10, 2020
08:30AM EST  Aspira Womens Health, Inc. Strengthens Executive   GlobeNewswire Inc
Nov 9, 2020
08:00AM EST  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced the appointment ofSandraE. Brooks, MD, MBA to its Board of Directors. The addition of Dr. Brooks brings the Board composition to seven members with the majority now female.   GlobeNewswire Inc
Nov 4, 2020
08:00AM EST  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced it will report financial results for the third quarter ended September 30, 2020 on Thursday, November 12, 2020 after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.   GlobeNewswire Inc
Oct 30, 2020
10:31AM EDT  Aspira Womens Healths shares are trading higher after William Blair initiated coverage on the stock with an Outperform rating.   Benzinga
10:06AM EDT  Benzinga's Top Upgrades, Downgrades For October 30, 2020   Benzinga
06:13AM EDT  William Blair Initiates Coverage On Aspira Womens Health with Outperform Rating   Benzinga
Oct 14, 2020
08:00AM EDT  Aspira Womens Health Inc. Announces it is now an   GlobeNewswire Inc
Oct 9, 2020
08:00AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it has been invited to present at the MicroCap Rodeo Best Ideas Bowl, which is being held virtually on October 13th - 16th, 2020.   GlobeNewswire Inc
Sep 15, 2020
05:01PM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced that it will host a key opinion leader (KOL) call on ovarian cancer diagnostics, innovation pipeline, and rebranding initiatives on Friday, September 25, 2020 at 12:00pm Eastern Time.   GlobeNewswire Inc
Sep 8, 2020
11:44AM EDT  Aspira Womens Health, Inc. to Present at Cantor   GlobeNewswire Inc
Aug 14, 2020
03:52PM EDT  Aspira Womens Health Inc. (ASPIRA) (Nasdaq: AWH), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2020.   GlobeNewswire Inc
Aug 13, 2020
04:09PM EDT  Aspira Womens Health Q2 EPS $(0.04) Up From $(0.06) YoY, Sales $746.00K Down From $1.14M YoY   Benzinga
04:01PM EDT  Aspira Womens Health Inc. (ASPIRA) (Nasdaq: AWH), a bio-analytical based womens health company focused on gynecologic disease, today reported its financial results for the second quarter ended June 30, 2020.   GlobeNewswire Inc
04:03AM EDT  Earnings Scheduled For August 13, 2020   Benzinga
Jul 31, 2020
09:23AM EDT  Aspira Womens Health, Inc. (Nasdaq: AWH), a bioanalytical-based womens health company, today announced it will report financial results for the second quarter ended June 30, 2020 on Thursday, August 13, 2020 after the market close, followed by an investor conference call and webcast at 4:30 p.m. Eastern Time.   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC